PON1 and myocardial infarction: Interestingly, following 6 months of HP-EVOO consumption, serum PON-1 activity exhibited a significant increase in post-MI patients compared to baseline (PMI: mean difference compared to baseline = 3.68 ± 11.90 U/mL, p = 0.014) (Figure 4).